| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | US IPO Week Ahead: November's IPO market set for a quiet start | ||
| Fr | US IPO Weekly Recap: Anthropic files for potentially record-breaking IPO | ||
| Fr | SPAC UCSB Acquisition files for a $60 million IPO, targeting businesses with competitive advantages and growth potential | ||
| Fr | Immunology and inflammation biotech Bambusa Therapeutics prices upsized IPO at $16 midpoint | ||
| Fr | Parkinson's disease biotech Aspen Neuroscience prices IPO at $15, the low end of the range | ||
| Fr | Emerging markets fintech OPay prices US IPO at $19, the low end of the range | ||
| Do | Singapore-based logistics firm Tracx Logis cuts deal size by 33% ahead of $20 million US IPO | ||
| Do | Dallas-area stone countertop fabricator KAT Construction Services files for a $20 million IPO | ||
| Do | SPAC Redwoods Acquisition II files for a $75 million IPO, targeting energy storage, telecom, and consumer businesses | ||
| Do | Natural pest control maker Med-X increases shares registered by 23% ahead of Nasdaq direct listing | ||
| Do | SPAC BHAV Acquisition II prices $100 million IPO, targeting robotics, fintech, computing, and energy tech | ||
| Do | Georgia Banking Company announces Nasdaq direct listing on October 29 | ||
| Mi | Singapore-based digital ad network Focus Media Network files for a $25 million US IPO | ||
| Mi | IPO Weekly Weigh-in: Anthropic's one share to rule them all | ||
| Di | SPAC Heroic Empire Acquisition files for a $100 million IPO, targeting AI, biotech, energy, and manufacturing | ||
| Di | Regenerative medicine device provider RegenLab USA sets terms for $18 million IPO | ||
| Di | SPAC SPACCircle Acquisition prices $100 million IPO, targeting digital assets, tech, and healthcare | ||
| Mo | SPAC Aimei Health Technology II increases unit offering by 67% ahead of $100 million IPO | ||
| Mo | Laser-based uranium enrichment developer LIS Technologies files for a $17 million IPO | ||
| Mo | AI model developer Anthropic PBC files for an estimated $75 billion IPO, teeing up one of the largest-ever IPOs for mid-November | ||
| Mo | Parkinson's disease biotech Aspen Neuroscience sets terms for $150 million IPO | ||
| Mo | Immunology and inflammation biotech Bambusa Therapeutics sets terms for $150 million IPO | ||
| 24.10. | US IPO Week Ahead: Africa-focused fintech target's week sole IPO as Anthropic nears its public filing | ||
| 24.10. | US IPO Weekly Recap: Trickle of biotech activity continues amid tech sell-off | ||
| 24.10. | SPAC: BHAV Acquisition II lowers deal size by 33% ahead of $100 million IPO |